Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy Grant US-11717548-B2 United States of America 08 Aug 2023
LIPIDNANOPARTICLE COMPRISING MODIFIED NUCLEOTIDES Application WO-2022020811-A1 World Intellectual Property Organisation (WIPO) 27 Jan 2022
COMPOSITIONS, METHODS AND USES OF MESSENGER RNA Application WO-2021072172-A1 World Intellectual Property Organisation (WIPO) 15 Apr 2021